MADRS PDF Download
Montgomery-Åsberg Depression Rating Scale
Clinician-rated scale sensitive to antidepressant treatment effects, widely used in clinical trials.
First 5 patients free forever
Catch early warning signs before the next session
The MADRS is the preferred clinician-rated depression scale in clinical trials
When to Use the MADRS
MADRS Scoring Guide (Score Range: 0-60)
| Score | Severity Level | Clinical Action |
|---|---|---|
| 0-6 | Normal | No depression |
| 7-19 | Mild | Monitor |
| 20-34 | Moderate | Treatment recommended |
| 35-60 | Severe | Intensive treatment |
Key Features of the MADRS
- Clinician-administered
- Sensitive to change
- Clinical trial standard
What the MADRS Actually Measures
The MADRS focuses on the core psychological symptoms of depression rather than somatic symptoms. Its 10 items were specifically selected for sensitivity to change, making it the preferred outcome measure in antidepressant trials and treatment monitoring.
Apparent Sadness (Item 1)
Clinician-observed dejection, gloom, and despair—rated based on facial expression, posture, and voice
Reported Sadness (Item 2)
Patient's subjective experience of depressed mood—regardless of visible expression
Inner Tension (Item 3)
Feelings of ill-defined discomfort, edginess, panic, and dread—captures anxious depression
Reduced Sleep (Item 4)
Duration and depth of sleep compared to normal—includes difficulty falling and staying asleep
Reduced Appetite (Item 5)
Loss of appetite compared to normal—forced eating may be required
Concentration Difficulties (Item 6)
Difficulty collecting thoughts, reading, or following conversations—key cognitive symptom
Lassitude (Item 7)
Difficulty getting started, slowness in daily activities—captures motivational deficit
Inability to Feel (Item 8)
Reduced emotional engagement with surroundings, activities, and people—emotional blunting
Pessimistic Thoughts (Item 9)
Guilt, inferiority, self-reproach, sinfulness, remorse—cognitive distortions
Suicidal Thoughts (Item 10)
Feeling life is not worth living, death wishes, suicidal plans—critical safety item
What Scores Actually Mean in Practice
Absence of significant depression. This is the target endpoint in treatment trials. Patient is functioning normally.
Clinician observes normal affect and engagement. Patient reports feeling like themselves again.
Mild depressive symptoms. May represent residual symptoms after treatment or subclinical depression. Monitor for worsening.
Clinician notes some reduced affect but patient remains functional. Some days better than others.
Moderate depression warranting active treatment. Most clinical trials require MADRS ≥20 for inclusion. Clear functional impairment.
Clinician observes consistent low mood, reduced engagement, visible distress. Patient reports struggling with daily life.
Severe depression requiring intensive treatment. Consider combination therapy, ECT referral, or hospitalization if safety concerns.
Clinician observes profound sadness, psychomotor changes, minimal engagement. Patient may express hopelessness or suicidal thoughts.
Common Misinterpretations
MADRS and HAM-D scores can be compared directly
MADRS has a 0-60 range while HAM-D ranges 0-52 with different item weighting. MADRS emphasizes psychological symptoms; HAM-D emphasizes somatic. A MADRS of 20 ≈ HAM-D of 14-17, but conversions are imprecise.
The MADRS is less comprehensive because it has fewer items
The MADRS's 10 items were specifically selected for sensitivity to change. It intentionally excludes somatic symptoms that may confound treatment response (e.g., sedation from medication counted as 'improved sleep').
A 50% reduction in MADRS score equals treatment response
While 50% reduction is a common trial definition, it can be misleading. A patient going from MADRS 40 to 20 is still moderately depressed. Remission (MADRS ≤6-10) is the clinically meaningful target.
The MADRS captures anxiety adequately through 'inner tension'
Item 3 (inner tension) provides some anxiety assessment, but for comorbid anxiety disorders, pair with GAD-7 or HAM-A. Inner tension reflects anxious depression, not anxiety disorders per se.
Clinician-rated scales are always more accurate than self-report
MADRS requires trained raters for reliability. Untrained clinicians may over- or under-rate based on their own mood or patient presentation. Use SIGMA structured interview guide for standardization.
What a MADRS of 35+ Usually Means for Treatment Retention
Patients with severe depression (MADRS ≥35) present with the profound psychological symptoms the MADRS was designed to capture—inability to feel, deep pessimism, and pervasive lassitude. These symptoms directly undermine treatment engagement in ways that require proactive clinical intervention.
Key Retention Strategies:
- Lassitude (Item 7) directly predicts appointment no-shows—patients literally cannot initiate the act of attending
- Inability to Feel (Item 8) reduces therapeutic alliance formation—patients may not experience the clinician as helpful
- Pessimistic Thoughts (Item 9) create hopelessness about treatment before it begins
- High Inner Tension (Item 3) may cause avoidance of emotionally activating therapy sessions
- Concentration Difficulties (Item 6) impair learning in therapy and medication education
- Suicidal Thoughts (Item 10) require immediate safety planning and may necessitate higher-intensity contact
- The MADRS's psychological focus means these patients often look 'more functional' than they feel—don't underestimate impairment
- Consider measurement-based care with weekly MADRS to demonstrate early improvement and maintain hope
- Early response (week 2-4) on the MADRS predicts ultimate outcome—non-responders need rapid treatment adjustment
Frequently Asked Questions About the MADRS
What is the MADRS?
The MADRS (Montgomery-Åsberg Depression Rating Scale) is a 10-item clinician-administered scale measuring depression severity.
How does the MADRS differ from the PHQ-9?
The MADRS is clinician-rated while the PHQ-9 is self-reported. MADRS is more sensitive to change and preferred in clinical trials.
You're not alone, and help is available.
If you are experiencing thoughts of suicide or feel at risk of harming yourself, please contact emergency services right away or reach out to the 988 Suicide & Crisis Lifeline (call or text 988 in the U.S.). If you are in immediate danger, call 911.
Related Assessments
Research Supporting Outcome Measurement
Evidence-based research on the importance of patient-reported outcome measures in behavioral health treatment.
Need Digital MADRS Tracking?
TouchpointHQ offers automated MADRS scoring, trend tracking, and clinical alerts. First 5 patients are free forever.